Physical Activity for Chronic Kidney Disease
(PACKD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how a 12-week exercise program can help teens with chronic kidney disease (CKD) become more active. Participants will try various exercise plans, which may include step goals, feedback, and financial incentives to determine the most effective method for increasing physical activity. Teens aged 13-18 with CKD who aren't on dialysis and can walk are suitable candidates for this study. As an unphased trial, this study provides a unique opportunity for teens to explore personalized exercise plans that could enhance their health and well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this physical activity intervention is safe for adolescents with chronic kidney disease?
Past studies have shown that physical activity and exercise are safe for people with chronic kidney disease (CKD). Research indicates that when done carefully, exercise is well-tolerated by those with CKD. No major reports of harmful effects have emerged when exercise increases gradually. In fact, exercise can offer many benefits, such as slowing the disease and improving overall health. This suggests that the physical activity in this trial is likely safe for participants.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to boost physical activity in people with chronic kidney disease. Unlike standard care, which might focus on medication or dietary changes, this trial investigates personalized exercise plans with step goals, financial incentives, and feedback. These elements aim to motivate participants and enhance their engagement in physical activity, potentially leading to better health outcomes. By testing various combinations, the trial seeks to determine the most effective strategy to improve physical activity participation in this population.
What evidence suggests that this trial's physical activity interventions could be effective for chronic kidney disease?
Research has shown that regular exercise greatly benefits people with chronic kidney disease (CKD). Studies have found that staying active can slow the progression of CKD and enhance overall quality of life. For instance, high-intensity interval training significantly reduces the risk of rapid kidney deterioration. Exercise also addresses other health issues often associated with CKD, such as high blood pressure and diabetes. This trial will explore various physical activity interventions, including personalized plans with step goals, financial incentives, and feedback, to assess their effectiveness in increasing physical activity participation among individuals with CKD. Overall, staying active can significantly impact those managing CKD.23678
Who Is on the Research Team?
Amy Kogon, MD MPH
Principal Investigator
Children's Hospital of Philadelphia
Are You a Good Fit for This Trial?
This trial is for adolescents with Chronic Kidney Disease (CKD) stages II-V who are not on dialysis or haven't had a transplant. Participants must understand English and have parental/guardian consent, plus child assent if needed.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week physical activity intervention to increase moderate to vigorous physical activity by 15 min/day
Follow-up
Participants are monitored for changes in physical activity and other health measures 3 months after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Physical Activity Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator